New recommendations focused on psychological intervention may help manage or reduce the impact of functional seizures.
Individuals with focal onset epilepsy treated with azetukalner experienced sustained monthly seizure reduction and evidence of seizure freedom up to 48 months, according to data presented at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback